Efficacy of oral pharmacological treatments in dyskinetic cerebral palsy: a systematic review.
Riccardo MassonEmanuela PaglianoGiovanni BaranelloPublished in: Developmental medicine and child neurology (2017)
Evidence to prove (or disprove) the efficacy of oral drugs in dyskinetic cerebral palsy is low. The most investigated drugs, trihexyphenidyl and levodopa, show contradictory results. Tetrabenazine, levetiracetam, and gabapentin efficacy should be studied in more detail. Lack of evidence is partially due to the inconsistency of classifications and outcome measures used. Outcome measures should be selected within the framework of the International Classification of Functioning, Disability and Health in next clinical trials.